LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged genetically modified · clear

Federal Circuit

Oregon Bill Would Create Trespass Cause of Action for Landowners Against GMO Patent Owners

Written by Rebecca L. Wright , Ph.D. and Eric Furman , Ph.D. In an ongoing set of disputes in Oregon between farmers and corporations that hold GMO patents, farmers may be given a new tool. Oregon House Bill 2739[1] “allows a cause of action against…

March 28, 2017·Federal Circuit·3 min read
Unsorted

Monsanto provides royalty-free access to agricultural biotechnology, but at what cost?

A new announcement last month from Monsanto Company could have tremendous impact in both agriculture and patent allocation for genetic modification of seeds for crop growth. In an unprecedented move, Monsanto will provide royalty-free research licenses to…

October 17, 2012·Unsorted·4 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data